QuantumLead homepage Small Molecules: Hit identification

Virtual Screening Services

Quantum is a leading company providing compound screening services in-silico. We apply our proprietary computational technology QUANTUM to identify potential strong inhibitors for a given protein target. QUANTUM shows outstanding accuracy in forecasting binding affinities of protein inhibitors. The hit rate of the screening produced by QUANTUM is in range of 10 - 50%.

We specialize in identifying proper 3D-structure of the target-protein and advise you regarding which libraries of compounds should be chosen for screening. If 3D structure of the protein of your choice is not available, or not exist, then we can build its 3D force field homology model, which can be further used for screening.

QUANTUM hit Identification technology
QUANTUM technology advantages
QUANTUM technology description and a summary of the key capabilities

Quantum can assist in analyzing drug hits and in initiating hit-to-lead programs. Please, contact Quantum to discuss your library screening project.

Use this form to contact us and inquire about Quantum's virtual screening services. Please fill in your email address and expect our representative contact you.

email:


 
Quantum Pharmaceuticals
 

Design by Netrider.ru 2004 (c) Quantum Pharmaceuticals 2004-2008 Computer Aided Drug Design & ADMET